BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Nokia
NOK
$24.6B
| $10.1K | ﹤0.01% |
2,200
-3,398
| -61% | -$15.7K |
|
|
ARCE
2927
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $10.1K | ﹤0.01% |
676
-259
| -28% | -$3.87K |
|
|
CSSE
2928
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $9.75K | ﹤0.01% |
1,316
-172
| -12% | -$1.28K |
|
2929
Standard BioTools
LAB
$489M
| $9.66K | ﹤0.01% |
6,035
-12,038
| -67% | -$19.3K |
|
2930
Mistras Group
MG
$301M
| $9.56K | ﹤0.01% |
1,609
-5,713
| -78% | -$33.9K |
|
2931
Smith Micro Software
SMSI
$15.3M
| $9.55K | ﹤0.01% |
483
-28
| -5% | -$553 |
|
2932
Renovaro
RENB
$47.8M
| $9.53K | ﹤0.01% |
4,937
+4,851
| +5,641% | +$9.36K |
|
2933
Cue Biopharma
CUE
$58.6M
| $9.02K | ﹤0.01% |
3,621
-3,780
| -51% | -$9.41K |
|
|
AMRN
2934
Amarin Corp
AMRN
$310M
| $8.96K | ﹤0.01% |
+301
| New | +$8.96K |
|
2935
Coca-Cola Femsa
KOF
$17.8B
| $8.85K | ﹤0.01% |
+160
| New | +$8.85K |
|
2936
Aldeyra Therapeutics
ALDX
$333M
| $8.78K | ﹤0.01% |
2,200
-5,268
| -71% | -$21K |
|
|
ONCT
2937
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $8.74K | ﹤0.01% |
394
-734
| -65% | -$16.3K |
|
2938
iShares Exponential Technologies ETF
XT
$3.55B
| $8.72K | ﹤0.01% |
182
-245
| -57% | -$11.7K |
|
2939
Ardelyx
ARDX
$1.6B
| $8.53K | ﹤0.01% |
14,460
+3,955
| +38% | +$2.33K |
|
|
TCRR
2940
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $8.41K | ﹤0.01% |
2,901
-91,594
| -97% | -$266K |
|
|
BFX
2941
DELISTED
BowFlex Inc.
BFX
| $8.36K | ﹤0.01% |
4,779
-30,902
| -87% | -$54.1K |
|
2942
CPS Technologies
CPSH
$49.4M
| $8.33K | ﹤0.01% |
2,714
| – | – |
|
2943
Celcuity
CELC
$2.37B
| $8.33K | ﹤0.01% |
915
+18
| +2% | +$164 |
|
|
GRTS
2944
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $8.33K | ﹤0.01% |
3,440
-2,111
| -38% | -$5.11K |
|
2945
Telefonica
TEF
$29.9B
| $8.31K | ﹤0.01% |
1,619
-3,149
| -66% | -$16.2K |
|
|
HEP
2946
DELISTED
Holly Energy Partners, L.P.
HEP
| $8.3K | ﹤0.01% |
518
+117
| +29% | +$1.88K |
|
|
REV
2947
DELISTED
Revlon, Inc.
REV
| $8.08K | ﹤0.01% |
1,491
-185
| -11% | -$1K |
|
2948
McEwen Inc.
MUX
$742M
| $8.07K | ﹤0.01% |
1,838
+505
| +38% | +$2.22K |
|
|
AVDL
2949
Avadel Pharmaceuticals
AVDL
$1.54B
| $8.05K | ﹤0.01% |
+3,298
| New | +$8.05K |
|
|
ATNX
2950
DELISTED
Athenex, Inc. Common Stock
ATNX
| $7.86K | ﹤0.01% |
960
+566
| +144% | +$4.63K |
|